Potent β- Blockers, no intrinsic sympathetic activity, no β 1-receptor and β 2-receptor subtype selectivity. For hypertension, hypertension with renal insufficiency.

1-Methyl-3-[2-[(5-Methyl-1H-Imidazol-4-Yl)Methylsulfanyl]Ethyl]Thiourea

MSDS

CAS:34839-70-8

Molecular Formula:C9H16N4S2

Alias

More Information

Metiamidum; Metiamida; Sk&Methiamide; Metiamide

Brief Introduction

Metiamide is a histamine H2 receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate compound in the development of the successful anti-ulcer drug cimetidine (Tagamet).

Bupropion Hydrochloride

MSDS

CAS:34911-55-2

Molecular Formula:C13H18ClNO

Alias

More Information

Bupropion; Amfebutamone; 2-(Tert-Butylamino)-1-(3-Chlorophenyl)Propan-1-One; Amfebutamon

Brief Introduction

Bupropion is a safe and effective antidepressant widely used in clinic. In recent years, studies have found that it has a very good effect of quitting smoking and can greatly improve the success rate of active smoking cessation. Therefore, it has been approved as the only prescription smoking cessation drug in the United States.

2-[3-(Tert-Butylamino)-2-Hydroxypropoxy]Benzonitrile

MSDS

CAS:34915-68-9

Molecular Formula:C14H20N2O2

Alias

More Information

Stresson; Bunitrolol; Bunitrolol Hcl; Ko-1366; 2-Nitrilo-N-Tert-Butylphenoxypropanolamine; (Rs)-2-(3-(Tert-Butylamino)-2-Hydroxypropoxy)Benzonitril

Brief Introduction

β- Receptor blockers. The effect was 4 times stronger than propranolol and had little inhibitory effect on myocardium, about 1 / 2 of the latter. It is used for the treatment of arrhythmias, angina pectoris and hypertension such as atrial fibrillation and supraventricular tachycardia. It was listed in Federal Republic of Germany in 1985.

1-[4-(1H-Imidazol-5-Yl)Butyl]-3-Methylthiourea

MSDS

CAS:34970-69-9

Molecular Formula:C9H16N4S

Alias

More Information

Unii-Tn5A4Od2Tv; Burimamide; Chembl12160; Chebi:3221

Brief Introduction

Burimamide is an antagonist at the H2 and H3 histamine receptors. It is largely inactive as an H2 antagonist at physiological pH, but its H3 affinity is 100x higher. It is a thiourea derivative. Burimamide was first developed by scientists at Smith, Kline & French (SK&F; now GlaxoSmithKline) in their intent to develop a histamine antagonist for the treatment of peptic ulcers. The discovery of burimamide ultimately led to the development of cimetidine (Tagamet).

Inquiry (

/ 10

)

Clear All